Clinical Trial Update: Evaluating Safety, Tolerability, and Preliminary Efficacy of YSCH-01 Monotherapy and in Combination With Atezolizumab for Recurrent Glioblastoma [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial evaluating YSCH-01 as monotherapy and in combination with atezolizumab for recurrent glioblastoma, focusing on safety, tolerabilit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• YSCH-01

Snippet

Sponsor: Huashan Hospital | Conditions: Recurrent Glioblastoma | EARLY_Phase 1 | Status: RECRUITING